0001104659-23-035178.txt : 20230321
0001104659-23-035178.hdr.sgml : 20230321
20230321175138
ACCESSION NUMBER: 0001104659-23-035178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230320
FILED AS OF DATE: 20230321
DATE AS OF CHANGE: 20230321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ek John Frederick
CENTRAL INDEX KEY: 0001767921
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40344
FILM NUMBER: 23750687
MAIL ADDRESS:
STREET 1: 5964 LA PLACE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akoya Biosciences, Inc.
CENTRAL INDEX KEY: 0001711933
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 475586242
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CAMPUS DRIVE
STREET 2: 6TH FLOOR
CITY: MARLBOROUGH
STATE: MA
ZIP: 01762
BUSINESS PHONE: 855.896.8401
MAIL ADDRESS:
STREET 1: 100 CAMPUS DRIVE
STREET 2: 6TH FLOOR
CITY: MARLBOROUGH
STATE: MA
ZIP: 01762
4
1
tm239789-3_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-03-20
0
0001711933
Akoya Biosciences, Inc.
AKYA
0001767921
Ek John Frederick
100 CAMPUS DRIVE, 6TH FLOOR
MARLBOROUGH
MA
01762
0
1
0
0
CFO
0
Common Stock
2023-03-20
4
A
0
160000
0.00
A
160000
D
Employee Stock Option (Right to Buy)
7.60
2023-03-20
4
A
0
160000
0.00
A
2033-03-20
Common Stock
160000
160000
D
The restricted stock units shall vest in four (4) equal annual installments beginning on April 1, 2024, and annually thereafter until fully vested.
Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.
The options shall vest as follows: twenty-five percent (25%) shall vest on March 20, 2024 with the remainder vesting in 36 equal monthly installments beginning on April 20, 2024.
/s/ John Frederick Ek, by Brian McKelligon, as Attorney-in-Fact
2023-03-21